iBio Reports NHP Data on IBIO-610 With Semaglutide

iBio said nonhuman-primate data showed IBIO-610 plus semaglutide preserved muscle and shifted nearly all weight loss over eight weeks to fat. The headline describes twice-yearly dosing as a prospect.